Topiramate Capsule
Product Images NDC 23155-894

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 23155-894). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (92e1b0f5 936e 45ba 8c45 B83db87b60d0 01)

Structure (92e1b0f5 936e 45ba 8c45 B83db87b60d0 01)
Chemical structure diagram of the active ingredient Topiramate, showing its molecular framework with multiple ring structures and functional groups, including sulfonamide and ether moieties.*
FDA Label Image

Figure 1 (92e1b0f5 936e 45ba 8c45 B83db87b60d0 02)

Figure 1 (92e1b0f5 936e 45ba 8c45 B83db87b60d0 02)
A Kaplan-Meier curve showing cumulative rates for time to first seizure over 500 days, comparing Topiramate 50 mg/day and Topiramate 400 mg/day doses. The graph includes sample sizes (N=234 for 50 mg/day, N=236 for 400 mg/day) and a p-value of 0.0002 indicating statistical significance.*
FDA Label Image

Figure 2 (92e1b0f5 936e 45ba 8c45 B83db87b60d0 03)

Figure 2 (92e1b0f5 936e 45ba 8c45 B83db87b60d0 03)
A bar graph showing the change from baseline to double-blind phase in average monthly migraine rate (± standard error) across four groups: Placebo, Topiramate 50 mg/day, Topiramate 100 mg/day, and Topiramate 200 mg/day. Two studies (Study 11 in black bars and Study 12 in grey bars) are compared within each group. Statistical significance is indicated with asterisks (* p < 0.010, ** p < 0.001). Sample sizes for each group are noted above the bars.*
FDA Label Image

Avet-logo (92e1b0f5 936e 45ba 8c45 B83db87b60d0 04)

FDA Label Image

Avet-logo (92e1b0f5 936e 45ba 8c45 B83db87b60d0 05)

FDA Label Image

Container-label-15mg (92e1b0f5 936e 45ba 8c45 B83db87b60d0 06)

Container-label-15mg (92e1b0f5 936e 45ba 8c45 B83db87b60d0 06)
Topiramate Capsules (Sprinkle) 15 mg label for 60 capsules by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. The label lists dosage form as capsules, strength as 15 mg, provides storage instructions, and contains manufacturer contact details. It includes cautionary statements to keep medication out of children's reach and to dispense with a medication guide.*
FDA Label Image

Container-label-25mg (92e1b0f5 936e 45ba 8c45 B83db87b60d0 07)

Container-label-25mg (92e1b0f5 936e 45ba 8c45 B83db87b60d0 07)
Topiramate Capsules (Sprinkle) 25 mg box label from Avet Pharma. The label states the product contains 60 capsules and is labeled for prescription use only. Manufactured by Strides Pharma Science Ltd. in India and distributed by Avet Pharmaceuticals Inc. in East Brunswick, NJ. The label includes storage instructions, dispensing information, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.